1-3 of 3
John Harpel, MD/PhD
Close
Sort by
Journal Articles

Cyclophosphamide Overcomes the Suppressive Effect of LenalidomideTherapy on Stem Cell Collection in Preparation for Autologous Stem Cell Transplantation for Multiple Myeloma.

Tomer Mark, MD, David Jayabalan, Roger N. Pearse, MD/PhD, Jessica Stern, Jessica Furst, April Rambo, RN, John Harpel, MD/PhD, Tsiporah Shore, MD, Michael Schuster, MD, John P. Leonard, MD, Paul J. Christos, MPH, Morton Coleman, MD, Ruben Niesvizky, MD
Journal: Blood
Blood (2007) 110 (11): 3024.
https://doi.org/10.1182/blood.V110.11.3024.3024
Published: 2007
Journal Articles

Breaking the Plateau Response in Myeloma: Preliminary Results of a Phase II Pilot Study of Sequential Bortezomib in Combination with Dexamethasone and Pegylated Liposomal Doxorubicin (DoVeD) in Patients No Longer Responsive to Standard Induction Regimens.

Brian A. Di Carlo, MD, Jessica L. Stern, Michael Schuster, MD, Tsiporah Shore, MD, John Harpel, MD, PhD, Roger Pearse, MD, PhD, Faiza Zafar, PA, Joanne Dymek, NP, Jessy Ryan, NP, David Jayabalan, MA, Selina Chen-Kiang, PhD, Scott Ely, MD, John P. Leonard, MD, Morton Coleman, MD, Ruben Niesvizky, MD
Journal: Blood
Blood (2006) 108 (11): 3538.
https://doi.org/10.1182/blood.V108.11.3538.3538
Published: 2006
Journal Articles

Depsipeptide in the Treatment of Relapsed and Refractory Multiple Myeloma (MM): A Prospective Evaluation of the Cell Cycle.

Zoe Goldberg*, MD, Scott Ely, MD, Selina Chen-Kiang, PhD, Martha Chesi, PhD, Peter L. Bergsagel, MD, Karen Pekle*, RN, Larry Lyons*, Udi Gelbshtein*, Roger Pearse, MD, PhD, John Harpel, MD, PhD, Hearn Cho, MD, PhD, Morton Coleman, MD, Ruben Niesvizky, MD
Journal: Blood
Blood (2004) 104 (11): 1497.
https://doi.org/10.1182/blood.V104.11.1497.1497
Published: 2004